TABLE OF CONTENTS
|  |  |  | Volume 32, Issue 4 (January 2013) |  | In this issue
Review
Original Articles
Corrigendum
Also new
   AOP
| |  |  |  | | Advertisement |  | New Year! New journal for your research!
Celebrate with 50% off the article processing charge
Submit your research to Blood Cancer Journal between January and March 2013 and receive 50% off the article processing charge.
This offer is for a limited time only.
Indexed by PubMed and Thomson Reuters.
Submit your research today and quote discount code BCJ50APC13 (Offer expires 31st March 2013) |
|  | | | Review | Top |  | Endometrial carcinoma: molecular alterations involved in tumor development and progressionA Yeramian, G Moreno-Bueno, X Dolcet, L Catasus, M Abal, E Colas, J Reventos, J Palacios, J Prat and X Matias-Guiu Oncogene 2013 32: 403-413; advance online publication, March 19, 2012; 10.1038/onc.2012.76 Abstract | Full Text |  | Original Articles | Top |  | microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherinF Muramatsu, H Kidoya, H Naito, S Sakimoto and N Takakura Oncogene 2013 32: 414-421; advance online publication, March 5, 2012; 10.1038/onc.2012.68 Abstract | Full Text |  |  |  | N-cadherin regulates mammary tumor cell migration through Akt3 suppressionS Chung, J Yao, K Suyama, S Bajaj, X Qian, O D Loudig, E A Eugenin, G R Phillips and R B Hazan Oncogene 2013 32: 422-430; advance online publication, March 12, 2012; 10.1038/onc.2012.65 Abstract | Full Text |  |  |  | MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrolY-H Yu, H-A Chen, P-S Chen, Y-J Cheng, W-H Hsu, Y-W Chang, Y-H Chen, Y Jan, M Hsiao, T-Y Chang, Y-H Liu, Y-M Jeng, C-H Wu, M-T Huang, Y-H Su, M-C Hung, M-H Chien, C-Y Chen, M-L Kuo and J-L Su Oncogene 2013 32: 431-443; advance online publication, March 12, 2012; 10.1038/onc.2012.74 Abstract | Full Text |  |  |  | UVB-induced COX-2 expression requires histone H3 phosphorylation at Ser10 and Ser28Y-S Keum, H-G Kim, A M Bode, Y-J Surh and Z Dong Oncogene 2013 32: 444-452; advance online publication, March 5, 2012; 10.1038/onc.2012.71 Abstract | Full Text |  |  |  | S6K1 determines the metabolic requirements for BCR-ABL survivalJ F Barger, C A Gallo, P Tandon, H Liu, A Sullivan, H L Grimes and D R Plas Oncogene 2013 32: 453-461; advance online publication, March 5, 2012; 10.1038/onc.2012.70 Abstract | Full Text |  |  |  | MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4N Agarwal, A S Adhikari, S V Iyer, K Hekmatdoost, D R Welch and T Iwakuma Oncogene 2013 32: 462-470; advance online publication, February 27, 2012; 10.1038/onc.2012.69 Abstract | Full Text |  |  |  | The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancerX Li, P D Stevens, H Yang, P Gulhati, W Wang, B M Evers and T Gao Oncogene 2013 32: 471-478; advance online publication, March 5, 2012; 10.1038/onc.2012.66 Abstract | Full Text |  |  |  | Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effectD Klokov, K Leskov, S Araki, Y Zou, E M Goetz, X Luo, D Willson and D A Boothman Oncogene 2013 32: 479-490; advance online publication, March 5, 2012; 10.1038/onc.2012.64 Abstract | Full Text |  |  |  | The molecular mechanism of microRNA-145 to suppress invasion–metastasis cascade in gastric cancerP Gao, A-Y Xing, G-Y Zhou, T-G Zhang, J-P Zhang, C Gao, H Li and D-B Shi Oncogene 2013 32: 491-501; advance online publication, February 27, 2012; 10.1038/onc.2012.61 Abstract | Full Text |  |  |  | Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis OpenK Shchors, H Nozawa, J Xu, F Rostker, L Swigart-Brown, G Evan and D Hanahan Oncogene 2013 32: 502-513; advance online publication, March 5, 2012; 10.1038/onc.2012.60 Abstract | Full Text |  |  |  | The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domainsJ-H Kim, S Yu, J D Chen and A N Kong Oncogene 2013 32: 514-527; advance online publication, February 27, 2012; 10.1038/onc.2012.59 Abstract | Full Text |  |  |  | Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusionI Psallidas, G T Stathopoulos, N A Maniatis, S Magkouta, C Moschos, S P Karabela, A Kollintza, D C M Simoes, M Kardara, S Vassiliou, S A Papiris, C Roussos and I Kalomenidis Oncogene 2013 32: 528-535; advance online publication, February 27, 2012; 10.1038/onc.2012.57 Abstract | Full Text |  | Corrigendum | Top |  | hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathwayC Massard, Y Zermati, A-L Pauleau, N Larochette, D Métivier, L Sabatier, G Kroemer and J-C Soria Oncogene 2013 32: 536; 10.1038/onc.2012.568 Full Text |  |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
|
|
No comments:
Post a Comment